145 related articles for article (PubMed ID: 16895576)
1. [Antibody and antibody-targeted therapy].
Becker JC
J Dtsch Dermatol Ges; 2006 Aug; 4(8):703. PubMed ID: 16895576
[No Abstract] [Full Text] [Related]
2. [Significance of monoclonal antibodies in the diagnosis and therapy of skin diseases].
Knopf B
Dermatol Monatsschr; 1986; 172(4):193-200. PubMed ID: 3721024
[No Abstract] [Full Text] [Related]
3. Therapeutic and drug delivery application of monoclonal antibodies.
Oates KK
Targeted Diagn Ther; 1990; 3():99-118. PubMed ID: 2131020
[No Abstract] [Full Text] [Related]
4. Infliximab as a therapy for idiopathic hypereosinophilic syndrome.
Taverna JA; Lerner A; Goldberg L; Werth S; Demierre MF
Arch Dermatol; 2007 Sep; 143(9):1110-2. PubMed ID: 17875870
[No Abstract] [Full Text] [Related]
5. A balancing act--making the right choices in anti-inflammatory drug development.
Elices MJ
Curr Opin Investig Drugs; 2007 May; 8(5):362-3. PubMed ID: 17520864
[No Abstract] [Full Text] [Related]
6. Targeted monoclonal antibody-based treatment of hematological malignancies.
Kaspers GJ
Expert Rev Anticancer Ther; 2003 Jun; 3(3):253-5. PubMed ID: 12820769
[No Abstract] [Full Text] [Related]
7. Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies.
Melero I; Murillo O; Dubrot J; Hervás-Stubbs S; Perez-Gracia JL
Trends Pharmacol Sci; 2008 Aug; 29(8):383-90. PubMed ID: 18599129
[TBL] [Abstract][Full Text] [Related]
8. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications.
Mitragotri S
Nat Rev Drug Discov; 2005 Mar; 4(3):255-60. PubMed ID: 15738980
[TBL] [Abstract][Full Text] [Related]
9. CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
van Meerten T; Hagenbeek A
Neth J Med; 2009; 67(7):251-9. PubMed ID: 19687518
[TBL] [Abstract][Full Text] [Related]
10. Antibody fusions with immunomodulatory proteins for cancer therapy.
Müller D
Pharmacol Ther; 2015 Oct; 154():57-66. PubMed ID: 26145167
[TBL] [Abstract][Full Text] [Related]
11. Antibody-targeted radiation cancer therapy.
Milenic DE; Brady ED; Brechbiel MW
Nat Rev Drug Discov; 2004 Jun; 3(6):488-99. PubMed ID: 15173838
[No Abstract] [Full Text] [Related]
12. [Monoclonal antibodies: also for dermatologists!].
Du-Thanh A; Guillot B
Med Sci (Paris); 2019 Dec; 35(12):1017-1021. PubMed ID: 31903911
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases.
Bujanover Y; Weiss B
Isr Med Assoc J; 2008; 10(8-9):634-9. PubMed ID: 18847168
[No Abstract] [Full Text] [Related]
14. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
[TBL] [Abstract][Full Text] [Related]
15. Timely lessons for target-based discovery of anti-inflammatory drugs.
Szymkowski DE
Drug Discov Today; 2005 Jan; 10(1):14-7. PubMed ID: 15676294
[No Abstract] [Full Text] [Related]
16. [Targeted therapy].
Becker JC; Hertl M
Hautarzt; 2008 Oct; 59(10):783-4. PubMed ID: 18779942
[No Abstract] [Full Text] [Related]
17. [Autoimmune skin diseases].
Beissert S; Hertl M
Hautarzt; 2015 Aug; 66(8):572-3. PubMed ID: 26228173
[No Abstract] [Full Text] [Related]
18. CD4 antibody therapy in chronic inflammatory dermatological diseases.
Morel P; Revillard JP; Nicolas JF; Wijdenes J
Immunol Ser; 1993; 59():271-6. PubMed ID: 8461392
[No Abstract] [Full Text] [Related]
19. Targeted therapies to improve tumor immunotherapy.
Begley J; Ribas A
Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
[TBL] [Abstract][Full Text] [Related]
20. FcgammaR: The key to optimize therapeutic antibodies?
Sibéril S; Dutertre CA; Fridman WH; Teillaud JL
Crit Rev Oncol Hematol; 2007 Apr; 62(1):26-33. PubMed ID: 17240158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
